跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SP-9
首页
药物
SP-9
SP-9
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Dihydro-benzo(1,4)oxazines
申请人: AVENTIS PHARMA LTD
优先权: 2000
US
Tumor vaccine signal peptide for enhancing HLA class I molecular antigen presentation and application thereof
申请人: SHENZHEN XINHE BIO MEDICINE TECH CO LTD
优先权: 2023
CN
Cancer treatment utilizing SP-141 to bind with MDM2 and act as an inhibitor of MDM2 expression
申请人: UNIV TEXAS TECH SYSTEM
优先权: 2015
US
RADICALLY POLYMERISABLE COMPOUND AND COMPOSITION
申请人: MUEHLBAUER TECH GMBH
优先权: 2023
EP
WO
2 件公开
Nucleic acids encoding chromophores/fluorophores and methods for using the same
申请人: CLONTECH LAB INC
优先权: 2006
US
2 件公开
Nucleic acids encoding chromophores/fluorophores and methods for using the same
申请人: CLONTECH LAB INC
优先权: 2001
US
8 件公开
Nucleic acids encoding chromophores/fluorophores and methods for using the same
申请人: CLONTECH LAB INC
优先权: 2006
US
10 件公开
Method for controlling total count of bacteria carried by artemia
申请人: UNIV SOUTH CHINA TECH
优先权: 2014
CN
药物
反馈